Follow us...

 

Search News Archives

 

Special Offers and Promotions

 

 

News Channels

 

Laboratory Products

 

 

View Channel

News

 

 

View Channel

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events
Swedish Biomimetics 3000

Swedish Biomimetics 3000

Swedish Biomimetics 3000

Products

Contact Swedish Biomimetics 3000


If you have not logged into the website then please enter your details below.

All articles from Swedish Biomimetics 3000

  SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines

SB3000 ApS solid phase, continuous manufacturing enabling technology has been awarded an Innobooster grant by the Danish Innovation Fund to further refine its ground-breaking technology and dramatically reduce the environmental impact of medicine production. SB3000 is initially focussed on peptide medicines where the existing batch process, on average, requires 4000 kgs of toxic solvents to produce one kilogram of medicine.

 

  SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology

Evaxion Biotech A/S has received funding from the Danish Innovation Fund to further develop their AI platform RAVEN to rapidly respond against future corona virus pandemics - from initial discovery to first in human trials in as little as 13 weeks. During those 13 weeks SB3000 intends to develop and validate a tailored μLOT® continuous manufacturing process for the vaccine at commercial scale. Being modular and easily transportable the μLOT® enabled production units can be deployed to sites across the world....

 

 

Media Partners